Alphabiom Corporation

Devices and technologies for orthopedic, trauma and neuro surgeries. Biomaterial and tissue engineering for bone substitutes and healing

Company Summary

Devices, biomaterials, and mininally invasive technologies for trauma, orthopedics surgery and neurosurgery market. About 25/1000 people have an orthopedic surgery, more have trauma surgery.Trauma and aging population drives growth of the global orthopedics devices market. Spinal devices are the fastest growing segment with a CAGR of 9.3%. By regulation, customers are mainly hospitals and independent physicians and/or their delegates.

Team

  • Fidele Likibi
    Presdent, CEO

    Ph.D., M.A.Sc. in BME (spine devices, bone substitutes). Postgraduate specializations in artificial organs, biomaterials, biomechanics, biostatistics). 12 years of experience in biomedical research at both private and academic institutions including Sainte-Justine Hospital and Biorthex Inc. in Montreal, Clinic Cecil and Gambro corp. in Lausanne (Switzerland), and West Virginia University in Morgantown (USA).

  • Fidele Likibi

Advisors

  • Taylor Leybow LLC
    Accountant
    Unconfirmed

Previous Investors

  • Dr. Aleksandra Laskowska Bruno (Italy)
    Unconfirmed
    Mr. Eldo Mabiala (Switzerland)
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free